Brachytherapy
Volume 8, Issue 3 , Pages 269-272 , July 2009

Point: Why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?

  • Susan E. Davidson

      Affiliations

    • Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom
    • Corresponding Author InformationCorresponding author. Department of Clinical Oncology, The Christie NHS Foundation Trust,Wilmslow Road, Withington , Manchester M20 4BX Tel: +44(0)161-446-3330; fax:+44-(0)161-446-8111.
    • ,
  • Jolyon H. Hendry

      Affiliations

    • Addlington, Cheshire, United Kingdom
    • ,
  • Catharine M. West

      Affiliations

    • Academic Department of Radiation Oncology, University of Manchester, United Kingdom

References 

  1. Implementation of image-guided brachytherapy for cervix cancer in the UK. A Royal College of Radiologists working party report. 2009.
  2. Pearce A, Craighead P, Kay I, et al. Brachytherapy for carcinoma of the cervix: A Canadian survey of practice patterns in a changing era. Radiother Oncol. 2009;91:194–196
  3. Guedea F, Ellison T, Venselaar J, et al. Overview of brachytherapy resources in Europe: A survey of patterns of care study for brachytherapy in Europe. Radiother Oncol. 2007;82:50–54
  4. Eifel PJ, Moughan J, Erickson B, et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: A patterns of care study. Int J Radiat Oncol Biol Phys. 2004;60:1144–1153
  5. Nag S. Controversies and new developments in gynaecologic brachytherapy: Image-based intracavitary brachytherapy for cervical carcinoma. Semin Radiat Oncol. 2006;16:164–167
  6. Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (Gyn)GEC-ESTRO Working Group (1): Concepts and terms in 3D image based treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CT. Radiother Oncol. 2005;74:235–245
  7. Potter R, Haie-Meder C, van Limbergen E, et al. Recommendations from Gynaecological (Gyn) GEC-ESTRO Working Group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67–77
  8. Nag S, Erikson B, Thomadsen B, et al. The American Brachytherapy Society recommendations for high dose rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201–211
  9. Lambin P, Gerbaulet A, Kramar A, et al. Phase III trial comparing two low dose rates in brachytherapy of cervix carcinoma: Report at two years. Int J Radiat Oncol Biol Phys. 1993;25:405–412
  10. Roberts SA, Hendry JH, Swindell R, et al. Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: A radiobiological analysis of a randomised clinical trial. Radiother Oncol. 2004;70:63–74
  11. Teshima T, Inoue T, Ikeda H, et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Cancer. 1993;72:2409–2414
  12. Haie-Meder C, Kramar A, Lambin P, et al. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys. 1994;29:953–960
  13. Fowler J, Mount M. Pulsed brachytherapy—The conditions for no significant loss of therapeutic ratio compared with traditional low dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1992;23:661–669
  14. Mourtada F, Gifford KA, Berner PA, et al. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids. Med Dosim. 2007;32:181–187
  15. Armour E, Wang ZH, Corry P, et al. Equivalence of continuous and pulse simulated low dose rate irradiation in 9L gliosarcoma cells at 37 degrees and 41 degrees C. Int J Radiat Oncol Biol Phys. 1992;22:109–114
  16. Chen CZ, Huang Y, Hall EJ, et al. Pulsed brachytherapy as a substitute for continuous low dose rate: An in vitro study with human carcinoma cells. Int J Radiat Oncol Biol Phys. 1997;37:137–143
  17. Mason KA, Thames HD, Ochran TG, et al. Comparison of continuous and pulsed low dose rate brachytherapy: Biological equivalence in vivo. Int J Radiat Oncol Biol Phys. 1994;28:667–671
  18. Armour EP, White JR, Armin A, et al. Pulsed low dose rate brachytherapy in a rat model: Dependence of late rectal injury on radiation pulse size. Int J Radiat Oncol Biol Phys. 1997;38:825–834
  19. Veninga T, Visser AG, van den Berg AP, et al. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation. Int J Radiat Oncol Biol Phys. 2001;49:1351–1360
  20. Haustermans K, Fowler J, Landuyt W, et al. Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate?. Radiother Oncol. 1997;45:39–47
  21. Pop LA, Millar WT, van der Plas M, et al. Radiation tolerance of rat spinal cord to pulsed dose rate (PDR-) brachytherapy: The impact of differences in temporal dose distribution. Radiother Oncol. 2000;55:301–315
  22. Pop LA, Millar WT, Visser AG, et al. Clinical implications of incomplete repair parameters for rat spinal cord: The feasibility of large doses per fraction in PDR and HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:215–226
  23. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 2004;59:242–249
  24. Fowler JF, Van Limbergen EFM. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in the tissues. Int J Radiat Oncol Biol Phys. 1997;37:877–883
  25. Fowler JF. Pulsed brachytherapy as a substitute for continuous low dose rate: Comment on Chen, Huang, Hall, and Brenner's paper. Int J Radiat Oncol Biol Phys. 1997;39:776
  26. Orton CG. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys. 2001;49:183–189
  27. Sminia P, Schneider CJ, Fowler JF. The optimal fraction size in high-dose-rate brachytherapy: Dependency on tissue repair kinetics and low-dose rate. Int J Radiat Oncol Biol Phys. 2002;52:844–849
  28. Visser AG, van den Aardweg GJ, Levendag PC. Pulsed dose rate and fractionated high dose rate brachytherapy: Choice of brachytherapy schedules to replace low dose rate treatments. Int J Radiat Oncol Biol Phys. 1996;34:497–505
  29. Millar WT, Hendry JH, Canney PA. The influence of the number of fractions and bi-exponential repair kinetics on biological equivalence in pulsed brachytherapy. Br J Radiol. 1996;69:457–468
  30. Brenner DJ, Schiff PB, Huang Y, et al. Pulsed-dose-rate brachytherapy: Design of convenient (daytime-only) schedules. Int J Radiat Oncol Biol Phys. 1997;39:809–815
  31. Fyles A, Keane TJ, Barton M, et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 1992;25:273–279
  32. Gasinska A, Fowler JF, Lind BK, et al. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. Acta Oncol. 2004;43:657–666
  33. Fodkal LU, Christensen JJ, Tanderup K, et al. Comparison of local control, survival and late morbidity between continuous low dose rate brachytherapy and pulsed dose rate brachytherapy in cervical cancer patients. Radiother Oncol. 2006;81:S252
  34. Rogers CL, Freel JH, Speiser BL. Pulsed low dose rate brachytherapy for uterine cervix carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:95–100
  35. Fyles A, Bachtiary B, Pintilie M, et al. Comparison of late toxicity between continuous low dose rate and pulsed dose rate brachytherapy in cervical cancer patients. Radiother Oncol. 2005;76:S14
  36. Bachtiary B, Dewitt A, Pintilie M, et al. Comparison of late toxicity between continuous low-dose-rate and pulsed-dose-rate brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys. 2005;63:1077–1082
  37. Charra-Brunaud C, Haie-Meder C, Peiffert D. Preliminary results of a prospective multicentric French study of PDR 3D brachytherapy for cervix carcinoma. Brachytherapy. 2008;7:96;(abs)
  38. Koedooder K, van Wieringen N, van der Grient HN, et al. Safety aspects of pulsed dose rate brachytherapy: Analysis of errors in 1,300 treatment sessions. Int J Radiat Oncol Biol Phys. 2008;70:953–960
  39. Hunter RD, Davidson SE. LDR/MDR brachytherapy for treating cervix cancer. In:  Joslin CAF,  Flynn A,  Hall EJ editor. Principles and practice of brachytherapy (using afterloading systems). Arnold publishers; 2000;p. 343–353
  40. Spensley S, Hunter RD, Livsey JE, et al. Clinical outcome for chemoradiotherapy in carcinoma of the cervix. Clin Oncol. 2009;21:49–55

PII: S1538-4721(09)00229-3

doi: 10.1016/j.brachy.2009.06.004

Brachytherapy
Volume 8, Issue 3 , Pages 269-272 , July 2009

Article Tools